DocMorris AG

DocMorris with accelerated and significant eRx growth in new customers, market share and revenue

DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025

DocMorris AG: DocMorris announces results of Tender Offer

DocMorris AG: Daniel Wüest becomes new CFO at DocMorris

DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2025

Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich

Final allocation of DocMorris CHF 200 million Convertible Bonds Offering

DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029

DocMorris launches approx. CHF 200 million Convertible Bonds due 2029

DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market

DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card

DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany

DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base

DocMorris optimises organisational structure and prepares for e-prescription growth in Germany

DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook

DocMorris: Solid basis for sustainable, profitable growth

DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions

DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024

DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024

New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)

Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)

Zur Rose Group has successfully completed the sale of its Swiss business to Migros

Zur Rose Group: Revenue in the first quarter 2023 in line with plan

Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023

Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability

Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany

Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected

Zur Rose Group takes next step towards profitability and further reduces complexity in Germany

Procurement and supply chain brought together under the new Chief Operations Officer

Zur Rose Group announces results of Tender Offer